Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FL1Q8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,716
Award facts
- Contract value 100% obligated
- $34,715.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34.7K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The delivery order, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, carries no set-aside designation. This award represents a discrete delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, valued at approximately $500 million and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide.
Nexplanon is a subdermal contraceptive implant, and this delivery order reflects the DLA's role in providing medical supplies and medications to Department of Defense healthcare systems. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts for branded and generic prescription drugs, biologics, and specialized medical consumables. The company's core business involves distributing pharmaceutical products to military and federal healthcare facilities, and this award exemplifies its ongoing support of DoD medical operations through the SPE2DB program vehicle that governs its relationship with the DLA.
Quick answers
Who was awarded contract SPE2DB25FL1Q8?
SPE2DB25FL1Q8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FL1Q8 worth?
The government has obligated $34,716 on SPE2DB25FL1Q8.
Is contract SPE2DB25FL1Q8 an order under another contract?
Yes. SPE2DB25FL1Q8 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL1Q8 competed?
The extent of competition for SPE2DB25FL1Q8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award